发明名称 |
LINKED DIBENZIMIDAZOLE ANTIVIRALS |
摘要 |
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
|
申请公布号 |
US2013295049(A1) |
申请公布日期 |
2013.11.07 |
申请号 |
US201213663741 |
申请日期 |
2012.10.30 |
申请人 |
ENANTA PHARMACEUTICALS, INC;ENANTA PHARMACEUTICALS, INC |
发明人 |
QIU YAO-LING;WANG CE;YING LU;PENG XIAOWEN;OR YAT SUN |
分类号 |
C07D403/14;A61K31/4184;A61K31/427;A61K31/444;A61K31/46;A61K31/496;A61K31/506;A61K31/517;A61K31/5377;A61K45/06;C07D401/14;C07D413/14;C07D451/02 |
主分类号 |
C07D403/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|